Ovid Therapeutics Inc.
OVID
$2.70
-$0.05-1.82%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 117.22M | 155.52M | 69.64M | 25.60M | 38.35M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 6.40M | 4.62M | 4.73M | 3.22M | 3.74M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 123.62M | 160.15M | 74.37M | 28.82M | 42.09M |
|
|
|||||
| Total Current Assets | 123.62M | 160.15M | 74.37M | 28.82M | 42.09M |
| Net Property, Plant & Equipment | 11.18M | 11.52M | 11.86M | 12.19M | 12.50M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.93M | 1.93M | 1.93M | 1.93M | 1.93M |
| Total Assets | 231.97M | 225.63M | 150.93M | 63.85M | 77.43M |
|
|
|||||
| Total Accounts Payable | 4.07M | 8.88M | 1.96M | 1.71M | 3.95M |
| Total Accrued Expenses | 4.24M | 10.66M | 4.90M | 2.96M | 2.87M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.48M | 1.46M | 1.43M | 1.41M | 1.38M |
| Total Finance Division Other Current Liabilities | 180.00K | 169.00K | -- | 718.00K | 718.00K |
| Total Other Current Liabilities | 180.00K | 169.00K | -- | 718.00K | 718.00K |
| Total Current Liabilities | 9.98M | 15.75M | 8.29M | 6.80M | 8.92M |
|
|
|||||
| Total Current Liabilities | 9.98M | 15.75M | 8.29M | 6.80M | 8.92M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 11.23M | 11.61M | 11.99M | 12.35M | 12.72M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 872.00K | -- | -- | -- | -- |
| Total Liabilities | 22.08M | 27.36M | 20.27M | 19.15M | 21.64M |
|
|
|||||
| Common Stock & APIC | 564.35M | 537.39M | 452.58M | 376.20M | 375.08M |
| Retained Earnings | -353.71M | -338.70M | -321.71M | -331.38M | -319.22M |
| Treasury Stock & Other | -750.00K | -422.00K | -202.00K | -126.00K | -69.00K |
| Total Common Equity | 209.89M | 198.27M | 130.66M | 44.70M | 55.79M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 209.89M | 198.27M | 130.66M | 44.70M | 55.79M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 209.89M | 198.27M | 130.66M | 44.70M | 55.79M |
|
|
|||||